38
STRUCTURAL HEART DISEASE PROGRAM
Generally , structural heart disease programs focus on diseases involving the heart ’ s valves or other noncoronary structures of the heart . When it comes to this specialized area , Baylor Scott & White Heart and Vascular Hospital – Dallas brings additional specialties into the discussion to provide individualized , multidisciplinary care .
This team includes interventional cardiologists and cardiac surgeons as well as echocardiology specialists , advanced imaging experts and electrophysiologists on the medical staff . Expertise from board certified cardiovascular anesthesiologists is also vitally important . These specialized anesthesiologists work in concert with the team , differentiating the Dallas campus from other treatment centers .
The program offers catheter-based and less invasive procedures , resulting in better outcomes for many patients . For example , the device used for transcatheter mitral valve repair has grown as a treatment option for patients with mitral regurgitation who are not candidates for surgical valve replacement . The program ’ s Center for Valve Disorders and Aortic Center received patients from all over Texas as well as the greater region in fiscal year 2022 for conditions needing advanced treatment options provided at Baylor Scott & White Heart and Vascular Hospital - Dallas . ( See dedicated sections for more information on these centers .)
Structural Heart Disease Program procedures include :
• Atrial septal defect ( ASD ) closure
• Left atrial appendage occlusion ( LAAO )
• Minimally invasive surgical repair of structural heart defects
• Minimally invasive surgical heart valve repair or replacement
• Minimally invasive tricuspid valve repair
• Patent foramen ovale ( PFO ) catheter repair
• Transcatheter aortic valve replacement - minimally invasive ( TAVR )
• Transcatheter mitral valve repair – minimally invasive ( TMVR )
• Transcatheter pulmonic valve replacement
• Percutaneous tricuspid valve repair
For more information about the Structural Heart Disease Program : 214.820.3604 .
KEY PUBLICATIONS
A sampling of key journal articles interventional cardiologists on the hospital ’ s medical staff authored in fiscal year 2022 are noted below .
• Cutlip DE , Jauhar R , Meraj P , Garratt KN , Novack V , Novack L , Maillard L , Erglis A , Stoler R , Barakat M , Silber S . Five Year Outcomes of the COBRA Polyzene F NanoCoated Coronary Stent System . Cardiovascular Revascularization Medicine . 2022 .
• Kandzari DJ , Kirtane A , Mehran R , Price M , Simon DI , Latib A , Kedhi E , Abizaid A , Worthley S , Zaman A , Stoler R , Choi J , Kanitkar M , Conradie A , Tam C , Walton A , Gruberg L , Ando K , Lee L , Lung T , Windecker S , Stone GW . Clinical Outcomes According to Lesion Complexity in High Risk Bleeding Risk Patients Treated with 1-month Dual Antiplatelet Therapy Following PCI : Analysis from the Onyx ONE Clear Study . Catheterization and Cardiovascular Interventions . 2022 Feb : 99 ( 3 ): 583- 592 .
• Karmapaliotis D , Stoler , et al . Safety and Efficacy of Everolimus-Eluting Bioabsorbable Polymer Coated Stent in Patients with Long Coronary Lesions : The EVOLVE 48 Study . Catheterization and Cardiovascular Interventions . 2022 Feb : 99 ( 2 ): 373-380 .
• Kirtane A , Stoler R , et al . Primary Results of the EVOLVE Short DAPT Study : Evaluation of 3-month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer- Coated Everolimus-Eluting Stent . Circulation : Cardiovascular Interventions . 2021 ; March , 14 ( 3 ) 10144 .
• Markus R , Tandon , et al . Velocity encoded mitral valve inflow cine : A novel and more reproducible method to determine cardiac rest periods during coronary magnetic resonance angiography . JRSM Cardiovasc Dis . 2022 Mar 16 ; 11:20480040221087556 .
• Safirstein JG , Tehrani DM , Schussler JM , Reid N , Mukerjee K , Weber L , Liu H , Skenderian S , Simeon M , Yang T , Seto AH . Radial Hemostasis Is Facilitated With a Potassium Ferrate Hemostatic Patch : The STAT2 Trial . JACC Cardiovascular Interventions . 2022 February ; 15 ( 8 ): 810-819 .
• Yeh RW , Bachinsky W , Stoler R , Bateman C , Tremmel J , Abbot J , Dohad S , Batchelor W , Underwood P , Alloco D , Kirtane AJ . Rationale and Design of a Randomized Study Comparing the Agent Drug Coated Balloon to Plain Old Balloon Angioplasty in Patients With In-Stent Restenosis . Journal of the American Heart Association . 2021 ; Nov ; 241 : 101-107 .
Baylor Scott & White Heart and Vascular Hospital - Dallas | Structural Heart Disease Program